Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505484200 on November 4, 2005

J. Biol. Chem., Vol. 281, Issue 2, 982-992, January 13, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/2/982    most recent
M505484200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Messina, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Messina, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Insulin Enhances Growth Hormone Induction of the MEK/ERK Signaling Pathway*

Jie Xu{ddagger}, Adam B. Keeton{ddagger}, John L. Franklin{ddagger}, Xin Li{ddagger}, Derwei Y. Venable{ddagger}, Stuart J. Frank§, and Joseph L. Messina{ddagger}1

From the {ddagger}Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294, the §Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Department of Cell Biology, University of Alabama, Birmingham, Alabama 35294, and the Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, Alabama 35233

Growth hormone (GH) plays an important role in growth and metabolism by signaling via at least three major pathways, including STATs, ERK1/2, and phosphatidylinositol 3-kinase/Akt. Physiological concentrations of insulin promote growth probably by modulating liver GH receptor (GHR) levels in vivo, but the possible effects of insulin on GH-induced post-GHR signaling have yet to be studied. We hypothesized that short-term insulin, similar to the fluctuations that occur following feeding, affects GH-induced post-GHR signaling. Our present studies suggest that, in rat H4IIE hepatoma cells, insulin (4 h or less) selectively enhanced GH-induced phosphorylation of MEK1/2 and ERK1/2, but not GH-induced activation of STAT5 and Akt. Although insulin pretreatment altered GH-induced formation of Shc·Grb2·SOS complex, it did not significantly affect GH-induced activation of other signaling intermediates upstream of MEK/ERK, including JAK2, Ras, and Raf-1. Immunofluorescent staining indicated that insulin pretreatment facilitated GH-induced cell membrane translocation of MEK1/2. Insulin pretreatment also increased the amount of MEK association with its scaffolding protein, KSR. In summary, short-term insulin treatment of cultured, liver-derived cells selectively sensitized GH-induced MEK/ERK phosphorylation independent of JAK2, Ras, and Raf-1, but likely resulted from increased cell membrane translocation of MEK1/2. These findings suggest that insulin may be necessary for sensitization of cells to GH-induced ERK1/2 activation and provides a potential cellular mechanism by which insulin promotes growth.


Received for publication, May 19, 2005 , and in revised form, November 2, 2005.

* This work was supported by National Institutes of Health Grants DK40456 and DK62071 (to J. L. M.) and DK46395 (to S. J. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Pathology, Division of Molecular and Cellular Pathology, Volker Hall, G019, 1670 University Blvd., University of Alabama, Birmingham, AL 35294-0019. Tel.: 205-934-4921; Fax: 205-975-1126; E-mail: messina{at}path.uab.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Jin, N. J. Lanning, and C. Carter-Su
JAK2, But Not Src Family Kinases, Is Required for STAT, ERK, and Akt Signaling in Response to Growth Hormone in Preadipocytes and Hepatoma Cells
Mol. Endocrinol., August 1, 2008; 22(8): 1825 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ulucan, X. Wang, E. Baljinnyam, Y. Bai, S. Okumura, M. Sato, S. Minamisawa, S. Hirotani, and Y. Ishikawa
Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1662 - H1672.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
R. L. Walzem, R. A. Baillie, M. Wiest, R. Davis, S. M. Watkins, T. E. Porter, J. Simon, and L. A. Cogburn
Functional Annotation of Genomic Data with Metabolic Inference
Poult. Sci., July 1, 2007; 86(7): 1510 - 1522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, Z. Liu, T. L. Clemens, and J. L. Messina
Insulin Reverses Growth Hormone-induced Homologous Desensitization
J. Biol. Chem., August 4, 2006; 281(31): 21594 - 21606.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement